Directors and Officers Disclosure

SHINTR
Mon, Jun 30 2025 08:30 am

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Hallenstein Glasson Holdings Limited (HLG)
Date this disclosure made: 27 June 2025
Date of last disclosure: 21 June 2024

Director or senior manager giving disclosure
Full name(s): James Charles Glasson
Name of listed issuer: Hallenstein Glasson Holdings Limited (HLG)
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares (NZX code: HLG)
Nature of the affected relevant interest(s): James is a director of JCG Trustee Limited (JCG) (which will be the registered holder of the shares as trustee of the James Glasson Family Trust) and has control over the exercise of a right to vote attached to the shares as a director of JCG (alongside the other directors of JCG).
For that relevant interest-
Number held in class before acquisition or disposal: 373,831
Number held in class after acquisition or disposal: 671,758
Current registered holder(s): JCG Trustee Limited as trustee of the James Glasson Family Trust.
Registered holder(s) once transfers are registered: N/A

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: One transaction
Details of transactions requiring disclosure-
Date of transaction: 27 June 2025
Nature of transaction: Acquisition of ordinary shares off market
Name of any other party or parties to the transaction (if known): Timothy Charles Glasson
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: $2,300,000 (being $7.72 per share)
Number of financial products to which the transaction related: 297,927

If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details—
Whether relevant interests were acquired or disposed of during a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: N/A
Date of the prior written clearance (if any): N/A

Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products: Ordinary Shares (NZX code: HLG)
Nature of the relevant interest: Registered holder and beneficial owner
For that relevant interest,-
Number held in class: 141,233
Current registered holder(s): James Charles Glasson

Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 27/06/2025
Name and title of authorised person: Cameron Alderton, Group Chief Financial Officer


Announcement PDF


Markets News

Fisher & Paykel Healthcare helps NZX up 1%
Markets Market Close

Fisher & Paykel Healthcare helps NZX up 1%

Skellerup Holdings shares rose 5.1%. 

Retail

Warehouse drops guidance, loss now in scope

The retailer has raised the possibility of a full-year earnings loss.

Warehouse drops guidance, loss now in scope
Markets Analysis

Xero’s Melio ‘leap of faith’

The NZ-founded company’s giant-killer dreams in the US hinge on this huge bet. 

Xero’s Melio ‘leap of faith’